Chang‐Uk Lim
Impact in
- Oncology top 10%
- Cancer-related Molecular Pathways
Papers in
-
- DNA Repair Mechanisms 4
- Ubiquitin and proteasome pathways 3
- RNA modifications and cancer 3
- Oncology 10
- Cancer-related Molecular Pathways 6
- PARP inhibition in cancer therapy 2
- Co-authors
- Eugenia V. Broude (14 shared papers)Igor B. Roninson (14 shared papers)Mengqian Chen (5 shared papers)Martina S.J. McDermott (4 shared papers)Jiaxin Liang (4 shared papers)Serena Altilia (4 shared papers)Michael Shtutman (4 shared papers)Michael H. Fox (4 shared papers)
- Journals
- Cancer Research (6 papers)Cell Cycle (3 papers)Oncotarget (2 papers)Proceedings of the National Academy of Sciences (2 papers)Cells (2 papers)
- Partner nations
- United StatesRussiaHungary
In The Last Decade
Chang‐Uk Lim
21 papers receiving 627 citations
Peers
Comparison fields: 5 of 76
- Oncology 200
- Cancer Research 82
- Molecular Biology 350
- Cell Biology 75
- Pulmonary and Respiratory Medicine 103
Countries citing papers authored by Chang‐Uk Lim
This map shows the geographic impact of Chang‐Uk Lim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chang‐Uk Lim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chang‐Uk Lim more than expected).
Fields of papers citing papers by Chang‐Uk Lim
This network shows the impact of papers produced by Chang‐Uk Lim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chang‐Uk Lim. The network helps show where Chang‐Uk Lim may publish in the future.
Co-authors
The 25 scholars most cited alongside Chang‐Uk Lim, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 95 | |
| 2 | 2017 | 93 | |
| 3 | 2011 | 76 | |
| 4 | 2018 | 70 | |
| 5 | 2009 | 51 | |
| 6 | 2011 | 44 | |
| 7 | 2011 | 30 | |
| 8 | 2020 | 26 | |
| 9 | 2006 | 24 | |
| 10 | 2021 | 22 | |
| 11 | 2011 | 20 | |
| 12 | 2005 | 19 | |
| 13 | 2015 | 17 | |
| 14 | Abstract #5552: BSI-201 enhances the activity of multiple classes of cytotoxic agents and irradiation in triple negative breast cancer | 2009 | 13 |
| 15 | 2005 | 10 | |
| 16 | 2006 | 10 | |
| 17 | 2011 | 7 | |
| 18 | 2022 | 1 | |
| 19 | 2012 | 1 | |
| 20 | 2017 | 1 |
About Chang‐Uk Lim
Chang‐Uk Lim is a scholar working on Molecular Biology, Oncology, Pulmonary and Respiratory Medicine, Cancer Research and Genetics, having authored 23 papers that have together received 631 indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (6 papers), DNA Repair Mechanisms (4 papers), Advanced Breast Cancer Therapies (4 papers), Ubiquitin and proteasome pathways (3 papers), RNA modifications and cancer (3 papers), PARP inhibition in cancer therapy (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Cancer-related molecular mechanisms research (2 papers). The work is most often cited by research in Oncology (200 citations), Cancer Research (82 citations), Molecular Biology (350 citations), Cell Biology (75 citations) and Pulmonary and Respiratory Medicine (103 citations). Chang‐Uk Lim has collaborated with scholars based in United States, Russia and Hungary. Frequent co-authors include Eugenia V. Broude, Igor B. Roninson, Mengqian Chen, Martina S.J. McDermott, Jiaxin Liang, Serena Altilia, Michael Shtutman, Michael H. Fox, David J. Oliver and Hippokratis Kiaris. Their work appears in journals such as Cancer Research, Cell Cycle, Oncotarget, Proceedings of the National Academy of Sciences and Cells.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.